Thousands more UK black men to be invited for prostate cancer screening
Summary
The UK government will invite thousands more Black men to join a prostate cancer screening trial but will not start screening all men for the disease. The decision follows expert advice that widespread testing may cause more harm than good, but men with a high-risk gene mutation will be regularly screened.Key Facts
- Prostate cancer is the most common cancer in UK men, with over 64,000 cases yearly.
- The UK National Screening Committee recommended against using PSA blood tests for all men.
- Men with a BRCA2 gene mutation, which raises prostate cancer risk, will be screened every two years from ages 45 to 61.
- Around a few thousand high-risk men will be screened annually under this plan.
- A £20 million investment was announced to support prostate cancer research, including expanding the Transform screening trial.
- The trial will include more Black men aged 45 to 74 who have not had recent PSA or MRI tests.
- Some campaigners criticized the government for not widening screening to all Black men, citing concerns about health inequalities.
- The program rollout is expected to begin in 2027.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.